Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pancreatic SABR using peritumoral fiducials, triggered imaging and breath-hold.
Kisivan K, Farkas A, Kovacs P, Glavak C, Lukacs G, Mahr K, Szabo Z, Csima MP, Gulyban A, Toth Z, Kaposztas Z, Lakosi F. Kisivan K, et al. Among authors: mahr k. Pathol Oncol Res. 2023 Dec 21;29:1611456. doi: 10.3389/pore.2023.1611456. eCollection 2023. Pathol Oncol Res. 2023. PMID: 38188611 Free PMC article.
[Linac-based stereotactic ablative radiotherapy for pancreatic cancer with intrafractional triggered imaging].
Kisiván K, Erdélyesi D, Gutyina D, Sajti P, Gugyerás D, Farkas A, Glavák C, László Z, Somogyiné Ezer É, Máhr K, Szabó Z, Szabó H, Cselik Z, Gulybán Á, Petőné Csima M, Káposztás Z, Lakosi F. Kisiván K, et al. Among authors: mahr k. Magy Onkol. 2021 Mar 17;65(1):6-13. Epub 2021 Jan 25. Magy Onkol. 2021. PMID: 33730111 Free article. Hungarian.
Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving Surgery: A Real-World Experience.
Boér K, Kahán Z, Landherr L, Csőszi T, Máhr K, Ruzsa Á, Horváth Z, Budai B, Rubovszky G. Boér K, et al. Among authors: mahr k. Pathol Oncol Res. 2021 May 4;27:1609785. doi: 10.3389/pore.2021.1609785. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34257621 Free PMC article.
Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.
Rubovszky G, Kocsis J, Boér K, Chilingirova N, Dank M, Kahán Z, Kaidarova D, Kövér E, Krakovská BV, Máhr K, Mriňáková B, Pikó B, Božović-Spasojević I, Horváth Z. Rubovszky G, et al. Among authors: mahr k. Pathol Oncol Res. 2022 Jul 11;28:1610383. doi: 10.3389/pore.2022.1610383. eCollection 2022. Pathol Oncol Res. 2022. PMID: 35898593 Free PMC article.
Corrigendum: Systemic treatment of breast cancer. 1st Central-Eastern European professional Consensus Statement on breast cancer.
Rubovszky G, Kocsis J, Boér K, Chilingirova N, Dank M, Kahán Z, Kaidarova D, Kövér E, Krakovská BV, Máhr K, Mriňáková B, Pikó B, Božović-Spasojević I, Horváth Z. Rubovszky G, et al. Among authors: mahr k. Pathol Oncol Res. 2023 Jan 31;29:1610954. doi: 10.3389/pore.2023.1610954. eCollection 2023. Pathol Oncol Res. 2023. PMID: 36798671 Free PMC article.
Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor-Positive Metastatic Breast Cancer: The MANTA Phase 2 Randomized Clinical Trial.
Schmid P, Zaiss M, Harper-Wynne C, Ferreira M, Dubey S, Chan S, Makris A, Nemsadze G, Brunt AM, Kuemmel S, Ruiz I, Perelló A, Kendall A, Brown J, Kristeleit H, Conibear J, Saura C, Grenier J, Máhr K, Schenker M, Sohn J, Lee KS, Shepherd CJ, Oelmann E, Sarker SJ, Prendergast A, Marosics P, Moosa A, Lawrence C, Coetzee C, Mousa K, Cortés J. Schmid P, et al. Among authors: mahr k. JAMA Oncol. 2019 Nov 1;5(11):1556-1564. doi: 10.1001/jamaoncol.2019.2526. JAMA Oncol. 2019. PMID: 31465093 Free PMC article.
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma.
Choueiri TK, Powles T, Peltola K, de Velasco G, Burotto M, Suarez C, Ghatalia P, Iacovelli R, Lam ET, Verzoni E, Gümüş M, Stadler WM, Kollmannsberger C, Melichar B, Venugopal B, Gross-Goupil M, Poprach A, De Santis M, Schutz FA, Park SH, Nosov DA, Porta C, Lee JL, Garcia-Del-Muro X, Biscaldi E, Manneh Kopp R, Oya M, He L, Wang A, Perini RF, Vickery D, Albiges L, Rini B; LITESPARK-005 Investigators. Choueiri TK, et al. N Engl J Med. 2024 Aug 22;391(8):710-721. doi: 10.1056/NEJMoa2313906. N Engl J Med. 2024. PMID: 39167807 Clinical Trial.
[Multicentric Hungarian results of cabozantinib therapy in patients with metastatic kidney cancer based on real-world data].
Maráz A, Nagyiványi K, Balogh I, Bodoky G, Mangel L, Küronya Z, Géczi L, Torday L, Dudás S, Szűcs M, Nagy Z, Hornyák L, Zolcsák Z, Bassam A, Kocsis J, Keresztes T, Kullmann T, Máhr K, Solymosi T, Papdán T, Szabó I, Varga Z, Biró K. Maráz A, et al. Among authors: mahr k. Magy Onkol. 2023 Mar 29;67(1):1-10. Epub 2023 Feb 4. Magy Onkol. 2023. PMID: 36989491 Free article. Hungarian.
63 results